Danish pharmaceutical company Lundbeck is planning to aim at the Asian markets in future as Lundbeck predicts big decline in sales in Europe and the US according to Euroinvestor.
Asia is a market which we really do have ambitions to develop, so it will be a major growth factor to Lundbeck in the future,” said concern manager in Lundbeck, Ole Chrintz.
The Danish pharmaceutical company is already well established in Asia, but according to Ole Chrintz, the Asian market holds big possibilities.
This Wednesday Lundbeck widen their arrangement with Teva Pharmaceuticals to cover China, South Korea, Hong Kong, Malaysia, Thailand, and the Philippines.
